Stock Groups

Eli Lilly’s ‘game-changing’ diabetes drug could boost the stock, SVB Securities says


On September 17, 2020, the Eli Lilly logo was displayed on one of Eli Lilly’s San Diego offices.

Reuters| Reuters

Eli LillyAccording to SVB Securities, the new drug for diabetes, which could also treat obesity, may bring even greater gains to stock.